Literature DB >> 9023407

Hamartomas in the setting of chronic epilepsy: a clinicopathologic study of 13 cases.

E E Volk1, R A Prayson.   

Abstract

Hamartomas are a poorly defined group of lesions and a rare cause of chronic epilepsy. We studied 13 patients, nine males and four females, whose cause of seizures was attributed to a hamartoma. The patients ranged in age from 6 to 33 years (mean, 21 years). Seizure duration before surgery ranged from 1.5 to 22 years (mean, 10 years). Seven hamartomas were located on the right side and six on the left. Six were located in the frontal lobe, five in the temporal lobe, and two in the occipital lobe. Twelve patients underwent gross total resection of the lesion and one a partial resection. All consisted of a circumscribed, disorganized collection of glial cells, primarily astrocytes. Rarely a neuronal component was admixed. One lesion contained an increased number of small blood vessels. Eight (62%) hamartomas contained eosinophilic granular bodies, and focal microcalcification was observed in three lesions (23%). Adjacent cortical architectural abnormalities (cortical dysplasia) were identified in eight (62%) resection specimens. Necrosis, mitoses, and prominent cytological atypia were absent in all lesions. Differential diagnostic considerations include low grade astrocytoma, ganglioglioma, dysembryoplastic neuroepithelial tumor, and cortical dysplasia. Postoperatively, 10 patients (77%) had complete resolution or greater than 90% reduction of seizure frequency. Two patients (16%) developed recurrent seizures 8 and 13 months postoperatively. One patient who underwent a partial resection showed no decrease in seizure frequency. No lesion recurrence on imaging studies has been observed in the 12 patients who underwent gross total resection of their hamartoma during 1 to 51 months (mean, 14 months) follow-up. We conclude that hamartomas seen in the setting of chronic epilepsy are generally low-grade lesions that respond well to gross total resection. Circumscription and lack of significant cytological atypia help distinguish these lesions from other neoplastic causes of epilepsy. Hamartomas that arise in the setting of chronic epilepsy appear to be associated with increased incidence of cortical architectural abnormalities (cortical dysplasia) and represent maldevelopmental lesions.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9023407     DOI: 10.1016/s0046-8177(97)90111-8

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  6 in total

1.  Oligodendroglial hamartoma: a potential source of misdiagnosis for oligodendroglioma.

Authors:  Gianluca Marucci; Marco Giulioni; Matteo Martinoni; Lilia Volpi; Roberto Michelucci
Journal:  J Neurooncol       Date:  2010-06-08       Impact factor: 4.130

2.  Sudden death, febrile seizures, and hippocampal and temporal lobe maldevelopment in toddlers: a new entity.

Authors:  Hannah C Kinney; Amy E Chadwick; Laura A Crandall; Marjorie Grafe; Dawna L Armstrong; William J Kupsky; Felicia L Trachtenberg; Henry F Krous
Journal:  Pediatr Dev Pathol       Date:  2009 Nov-Dec

Review 3.  Fourth ventricle hamartoma presenting with progressive myoclonus and hemifacial spasms: case report and review of literature.

Authors:  Nelia Zamponi; Claudia Passamonti; Michele Luzi; Roberto Trignani; Luana Regnicolo; Marina Scarpelli
Journal:  Childs Nerv Syst       Date:  2011-04-06       Impact factor: 1.475

4.  Inheritance of febrile seizures in sudden unexplained death in toddlers.

Authors:  Ingrid A Holm; Annapurna Poduri; Laura Crandall; Elisabeth Haas; Marjorie R Grafe; Hannah C Kinney; Henry F Krous
Journal:  Pediatr Neurol       Date:  2012-04       Impact factor: 3.372

5.  Bilateral oligodendroglial hamartomas: A rare cause of drug-resistant epilepsy in a pediatric patient.

Authors:  Havisha Munjal; Devanshi Mistry; Jeevak Almast; Shehanaz Ellika
Journal:  J Clin Imaging Sci       Date:  2022-05-05

6.  Neuropathology of temporal lobe epilepsy.

Authors:  Fahd Al Sufiani; Lee Cyn Ang
Journal:  Epilepsy Res Treat       Date:  2012-04-12
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.